Samsung BioLogics says IPO expected to raise up to $2.04 billion



Samsung BioLogics Co Ltd said on Tuesday its planned initial public offering is expected to raise up to 2.25 trillion won (1.58 billion pounds).
Samsung BioLogics, Samsung Group's biopharmaceutical contract manufacturing unit, said in a regulatory filing that it is expected to offer 16.5 million shares via the initial public offering, with about 11 million new shares issued and about 5.5 million existing shares being floated.
The offering has an indicative range of 113,000-136,000 won per share, the company said.
(Reporting by Joyce Lee; Editing by Muralikumar Anantharaman)
read more

 
4 October 2016 in Business, Views: 68
Source: Reuters
Share:
  •  





    News Widget for Webmasters



    Bring Eugene's son back home immediately

    Realtime News

     

    «
    »
    Mo Tu We Th Fr Sa Su
          1 2 3 4
    5 6 7 8 9 10 11
    12 13 14 15 16 17 18
    19 20 21 22 23 24 25
    26 27 28 29 30 31